셀투인은 우수한 연구진과 뛰어난 팀웍을 바탕으로
미래 의학기술 발굴을 목표로 R&D에 전념하고 있습니다

셀투인은 연구개발 결과를 특허등록, 학술지 게재 및 국제학회 기술 발표를 통해
기술의 우수성과 신뢰성을 입증하고 있습니다.

지적재산권 확보

Cell2in은 글로벌 바이오 시장에서 고유 기술을 활용한 적극적 사업 전개를 위해 국내는 물론 신약개발 주요국가의 고품질 세포치료제 생산기술의 특허를 확보하고 있습니다.

물질 및 용도

Name of Technology Country of Application Application and Registration No. Applied and Registered Date
세포의 티올수준을 측정하기 위한
실시간 이미징 센서
Korea 10-1862581 2018. 05. 24
United States 10.215.757B2 2019. 02. 26
Korea 10-1983803 2019. 05. 23
United States 10.620.215 2020. 04. 14
세포의 소기관 내 글루타치온 측정용
실시간 형광 이미징 센서 및
이의 제조방법
Korea 10-2133794 2020. 07. 08
Canada (application) 3.072.434 2020. 02. 07
Australia (application) 2018320601 2020. 02. 19
United States (application) 16/640717 2020. 02. 20
Europe (application) 18848372.1 2020. 02. 21
China (application) 201880054675.0 2020. 02. 21
India (application) 202017007994 2020. 02. 25
Japan (application) 2020-511502 2020. 02. 19
소포체 내 글루타치온 측정용
실시간 형광 이미지 센서 및
이를 이용하는 방법
Korea 10-2019-0178260 2019. 12. 30

Gene Biomarker

Name of Technology Country of Application Application and Registration No. Applied and Registered Date
FreSHtracer 기반
분리된 세포의
유전자 프로파일의 응용
PCT PCT/KR 2018/008239 2018. 07. 20

Stem Cell Therapy

Name of Technology Country of Application Application and Registration No. Applied and Registered Date
혈소판 감소증
치료용 조성물
Korea 10-2021-0063975 2021. 05. 18
고품질의 줄기세포 선별용 마커 및
이를 이용한 고품질 줄기세포 선별 방법
Korea 10-2020-0180455 2020. 12. 22

Cell Quality Control

Name of Technology Country of Application Application and Registration No. Applied and Registered Date
실시간 글루타치온
측정을 통한
치료용 세포의
품질 향상 방법
Korea 10-2119714 2020. 06. 01
Europe (application) 18883520.1 2020. 05. 27
China (application) 201880077266.2 2020. 05. 28
Japan (application) 2020-546264 2020. 05. 27
United States (application) 16/767985 2020. 05. 28
실시간 글루타치온
측정을 통한
치료용 세포의
품질 측정 방법
Korea 10-2145929 2020. 08. 12
United States (application) 16/768014 2020. 05. 28
Europe (application) 18884812.1 2020. 05. 27
China (application) 201880077236.1 2020. 05. 28
Japan (application) 2020-546265 2020. 05. 27

기술 발표 및 게재

셀투인은 국내외 학회와 학술지를 통해 연구 성과를 지속적으로 발표해오고 있습니다.

Development Technology and senescent Cells : KB. Lee et al., Antioxidants reduce the heterogeneity of the intracellular glutathione level in senescent cell population of human dermal fibroblasts, J Dermatol Sci. (2020) 98(3),195-198

Accumulating evidence suggests that increased reactive
oxygen species (ROS) production has a role in inducing
senescence of human dermal
fibroblasts (HDFs) via the activation
of DNA damage and redox signaling pathways [1]. Unfortunately,
ROS-reducing antioxidant agents are only marginally effective in
delaying or preventing cellular senescence, even at a high
concentration [2,3]. We evaluated endogenous antioxidant
systems to better understand these
findings. Glutathione (GSH)
is the most abundant thiol-containing tripeptide that plays a
major role in eliminating H2O2 through a GSH peroxidase-
catalyzed reactions [4]. Moreover, GSH reduces oxidized proteins
through glutathionylation, thereby regulating the intensity and
duration of redox signaling. Thus, intracellular GSH level are
critical for maintaining redox homeostasis. Measuring GSH level
in live cells is challenging owing to the irreversible reaction of
fluorescent probes with GSH. We developed a new coumarin-
based GSH probe, FreSHtracer, which reversibly reacts with GSH
accompanied by spectral shifts in UV absorption (520 to 430 nm)
and
fluorescence emission (F580 to F510), allowing ratiometric
measurement of GSH in live cells [5]. Here, we monitored the
changes in GSH levels in HDFs during senescence and evaluated
the effect of antioxidants on GSH levels by measuring the F510/F580
ratio (FR).

학술지 게재

『Stem Cell Report』 Stem Cell Report
『The Journal of Clinical Investigation』 The Journal of Clinical Investigation
『Science Advances』 Science Advances

기술 발표

국제줄기세포학회 기술 발표 국제줄기세포학회 기술 발표